Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Automationguyon Feb 25, 2012 9:22pm
406 Views
Post# 19586381

RE: RE: RE: RE: Feb.29

RE: RE: RE: RE: Feb.29

FYI

PROGRAMACIÓN TALADROS 2011* Ver Gráfica Volver al índice
No. Compañía Nombre del equipo HP Equipo Capacidad del Top Drive (ton) Fast Moving Estado Operador(es) Campo(s)/ contrato(s) Depto. Municipio Fecha final de contrato
1 BETA ENERGY 350 IDECO H-35 (WO) N/A SI Contrato ECOPETROL CASABE ANTIOQUIA YONDÓ 2012-12-31
2 BETA ENERGY 600 LOADCRAFT N/A Contrato ECOPETROL CANTAGALLO BOLIVAR CANTAGALLO 2013-12-05
3 BETA ENERGY 600 LOADCRAFT N/A Contrato ECOPETROL CANTAGALLO BOLIVAR CANTAGALLO 2013-12-05
4 BETA ENERGY 750 WILSON 42B. DRILL 175 ton NO Adecuación
5 BETA ENERGY 750 WILSON 42B BD 175 ton Contrato ECOPETROL CAÑO SUR META DPTO. META 2012-08-31
6 BETA ENERGY 1200 LOADCRAFT 1200 HP 250 ton SI Adecuación
7 BETA ENERGY 1200 LOADCRAFT 1200 HP 250 ton Contrato P1 ENERGY CASANARE CASANARE MANÍ 2012-01-31
8 BETA ENERGY 1200 LOADCRAFT 1200 HP 250 ton Contrato ECOPETROL POZO: HABILA META SAN MARTIN 2011-09-30
9 CAROIL 1500 Ideco 500 Contrato PETROMINERALES Jamuco CASANARE Barranca de Upía Diciembre de 2013
10 CAROIL 1500 DRECO 500 Contrato PETROMINERALES Corcel Noreste CASANARE Barranca de Upía Diciembre de 2012
11 CAROIL 1500 DSI 500 Contrato C&C Energy Zopilote CASANARE Orocué Junio 30 de 2012
12 CAROIL 1500 Cooper 500 Contrato SK Energy Tamandú CUNDINAMARCA Paratebueno Febrero 28 de 2012
13 CAROIL 1500 DSI 500 Contrato PETROMINERALES META Maní Junio 30 de 2012
14 CAROIL 2000 Branham 500 Contrato PETROMINERALES Bloque 31 CASANARE Villanueva Octubre 31 de 2012
15 DISCOVERY 400 D-1 CARDWELL K-200C (WO) DRILL No SI Contrato Oxy y New Granada Miedo y Cabiona Casanare y Meta Yopal 31/06/2012
16 DISCOVERY 500 TAYLOR 500HP [W.O-D] No SI Contrato Emerald Los potros Casanare Yopal 2012-08-31
17 DISCOVERY 550 LOADCRAFT 550 HP (WO) No SI Contrato Quetzal Energy Canaguay Casanare Monterrey 2012-03-31
Bullboard Posts